Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Molecular basis of neurodegeneration in a mouse model of Polr3-related disease

ABSTRACT: Molecular basis of neurodegeneration in a mouse model of Polr3-related disease

PROVIDER: PRJNA1031683 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26502323.fastq.gz	Fastqsanger.gz
	SRR26502324.fastq.gz	Fastqsanger.gz
	SRR26502325.fastq.gz	Fastqsanger.gz
	SRR26502326.fastq.gz	Fastqsanger.gz
	SRR26502327.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 69

Similar Datasets

Molecular basis of neurodegeneration in a mouse model of Polr3-related disease (RNA)

Project description:Molecular basis of neurodegeneration in a mouse model of Polr3-related disease (RNA)

| PRJNA1031685 | ENA

Molecular basis of neurodegeneration in a mouse model of Polr3-related disease (tRNA)

Project description:Molecular basis of neurodegeneration in a mouse model of Polr3-related disease (tRNA)

| PRJNA1031687 | ENA

Molecular basis of neurodegeneration in a mouse model of Polr3-related disease (RNA)

Project description:Pathogenic variants in subunits of RNA polymerase (Pol) III cause a spectrum of neurodegenerative diseases including 4H leukodystrophy. We developed a postnatal whole-body mouse model expressing pathogenic mutations in Polr3a to examine the molecular mechanisms by which reduced Pol III activity results primarily in central nervous system phenotypes. Polr3a mutant mice exhibit behavioral deficits, exocrine pancreatic atrophy and cerebral pathology. Transcriptome and immunohistochemistry analyses of cerebra show a reduction in most Pol III transcripts, induction of innate immune and integrated stress responses and cell type-specific gene expression changes reflecting neuron and oligodendrocyte loss and microglial activation. A global decrease in mature tRNA levels and an altered tRNA profile preceded cerebral neurodegeneration suggesting a causal role in disease initiation. In cerebella, heart and kidney, Pol III transcripts other than tRNAs were generally unaffected. The results suggest tissue-specific thresholds of sensitivity to defects in Pol III transcription.

2024-01-10 | GSE246160 | GEO

Molecular basis of neurodegeneration in a mouse model of Polr3-related disease (tRNA)

2024-01-10 | GSE246161 | GEO

Molecular basis of neurodegeneration in a mouse model of Polr3-related disease

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-01-10 | GSE246162 | GEO

Molecular basis of Urostyle development

Project description:Molecular basis of Urostyle development

| PRJNA1017454 | ENA

Molecular basis of neurodegeneration in a mouse model of <i>Polr3</i>-related disease.

Project description:Pathogenic variants in subunits of RNA polymerase (Pol) III cause a spectrum of neurodegenerative diseases including 4H leukodystrophy. Disease onset occurs from infancy to early adulthood and is associated with a variable range and severity of neurological and non-neurological features. The molecular basis of disease pathogenesis is unknown. We developed a postnatal whole-body mouse model expressing pathogenic Polr3a mutations to examine the molecular mechanisms by which reduced Pol III transcription results primarily in central nervous system phenotypes. Polr3a mutant mice exhibit behavioral deficits, cerebral pathology and exocrine pancreatic atrophy. Transcriptome and immunohistochemistry analyses of cerebra during disease progression show a reduction in most Pol III transcripts, induction of innate immune and integrated stress responses and cell type-specific gene expression changes reflecting neuron and oligodendrocyte loss and microglial activation. Earlier in the disease when integrated stress and innate immune responses are minimally induced, mature tRNA sequencing revealed a global reduction in tRNA levels and an altered tRNA profile but no changes in other Pol III transcripts. Thus, changes in the size and/or composition of the tRNA pool have a causal role in disease initiation. Our findings reveal different tissue- and brain region-specific sensitivities to a defect in Pol III transcription.

| S-EPMC10760057 | biostudies-literature

Molecular Basis of Hereditary Retinal Degenerations

Project description:Molecular Basis of Hereditary Retinal Degenerations

| PRJNA475318 | ENA

Molecular Basis of Hereditary Retinal Degenerations

Project description:Molecular Basis of Hereditary Retinal Degenerations

| PRJNA475319 | ENA

Molecular basis of beige adipocyte maintenance

Project description:Molecular basis of beige adipocyte maintenance

| PRJEB11461 | ENA